CPT code 81234: DMPK test, expanded allele detection2026 Medicare lab fee · Clinical Laboratory Fee Schedule
DMPK testing detects abnormal expanded alleles associated with myotonic dystrophy type 1 when evaluating suspected disease or at-risk relatives.
Medicare pays $137.00 for 81234 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$137.00
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 81234 covers
This molecular genetic test evaluates the DMPK gene for abnormal expanded alleles associated with myotonic dystrophy type 1 (DM1). It is used when clinical findings prompt evaluation for DM1 and may also support testing of at-risk relatives. Molecular laboratories commonly analyze DNA from a blood specimen. The result addresses whether an abnormal expansion is detected, rather than characterizing the alleles in detail.
Report 81234 for evaluation to detect abnormal expanded DMPK alleles; 81239 is used when the service characterizes DMPK alleles. Medicare pays this test only through the CLFS. The 2026 national CLFS amount is $137.00, unchanged since 2020. One amount applies in every locality, with no geographic or office-versus-facility adjustment.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 81234
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 81234. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 81234 with status X (excluded by statute), so the test itself is paid only from the CLFS.
81234 on the lab fee schedule since 2020
81234 · CLFS 2026 Q4 (current)
$137.00
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
81234 compared with similar tests
- 81239DMPK testingAllele characterization$274.83
- Use 81234 to evaluate for abnormal expanded DMPK alleles. Use 81239 when the service characterizes DMPK alleles.
- 81243FMR1 testingAbnormal allele detection$57.04
- 81243 evaluates the FMR1 gene for abnormal alleles; 81234 evaluates DMPK for abnormal expanded alleles.
- 81244FMR1 testingAllele size and methylation$44.89
- 81244 characterizes FMR1 alleles. It concerns a different gene from the DMPK allele evaluation reported with 81234.
81234 billing questions
When should 81234 be reported instead of 81239?
Use 81234 to evaluate for an abnormal expanded DMPK allele. Use 81239 when the service characterizes DMPK alleles.
What specimen is commonly used?
Molecular laboratories commonly analyze DNA from a blood specimen for DMPK testing.
How does Medicare pay for this test?
Medicare pays 81234 through the CLFS at one national amount. The payment applies across localities and in office and facility settings.
What should the record support?
Document the clinical reason for evaluating DM1, the DMPK testing performed, and the result. The laboratory report can help distinguish expanded-allele detection from allele characterization.
What does 81234 evaluate?
It evaluates the DMPK gene for abnormal expanded alleles associated with myotonic dystrophy type 1.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 81234 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist